dr. richard finnell served as director 2001-2005 under whose leadership the texas institute for genomic medicine (tigm) was established. dr. robert schwartz served as director for 2006-2009. in 2007 a self-study called for a strategic plan in which the ibt would be the founding basic research element of a broader texas a&m health science center houston campus representing all components of the health science center in houston. dr. david carlson, the texas a&m health science center vice president of research and graduate studies served as the interim ibt director 2009-2011. in 2011 dr. cheryl lyn walker was appointed as the current director of ibt.